As part of the growing digital transformation in the biopharmaceutical R&D landscape, there is increased desire for sustainable efficiency gains using next generation technology, which includes automation.
Throughout the last three years, the life sciences industry has been trying to find a way to make the potential benefits of automation, such as reduced manual intervention in case processing, a reality for their organizations. However, very few organizations have been able to make any significant progress on making this a reality. It is therefore important to identify how biopharmaceutical companies can achieve these benefits both now and in the future, and move away from the hype that surrounds automation.
This webinar will: